KURA - Kura Oncology, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
11.0 0.26 (2.32%) 0.0 (0.0%) 0.01 (0.04%) 0.03 (0.22%) 0.01 (0.09%) 0.39 (3.54%) -0.17 (-1.55%) 0.03 (0.27%)

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.75
Diluted EPS:
-0.75
Basic P/E:
-15.0067
Diluted P/E:
-15.0067
RSI(14) 1m:
54.55
VWAP:
11.26
RVol:

Events

Period Kind Movement Occurred At

Related News